Interleukin-12 Treatment during Immunization Elicits a T Helper Cell Type 1-like Immune Response in Mice Challenged with Respiratory Syncytial Virus and Improves Vaccine Immunogenicity

Adjuvant effects of exogenous interleukin (IL)-12 on induction of immune responses against respiratory syncytial virus (RSV) infection in mice were evaluated. Giving recombinant IL-12 at the time of immunization with a formalin-inactivated alum-precipitated RSV preparation resulted in significant reduction of virus replication in lungs 4 days after RSV challenge. Intraperitoneal or intramuscular IL-12 was effective when given at the time of immunization but not at the time of challenge. IL-12 treatment resulted in increased interferon-γ mRNA in lungs, increased IgG2a RSV-specific antibody isotype utilization, and increased endogenous IL-12 p40 mRNA expression. IL-12 treatment did not significantly affect clinical outcome or cytotoxic T lymphocyte activity. These data demonstrate that IL-12 has potent adjuvant effects that may be due to induction of T helper cell type 1-like immune responses..

Medienart:

E-Artikel

Erscheinungsjahr:

1995

Erschienen:

1995

Enthalten in:

Zur Gesamtaufnahme - volume:172

Sprache:

Englisch

Beteiligte Personen:

Tang, Yi-Wei [VerfasserIn]
Graham, Barney S. [VerfasserIn]

Links:

Volltext

Themen:

Biological sciences
Health sciences
Physical sciences
Research-article

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

JST048855049